Viridian Therapeutics, Inc.DE
VRDNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$3.461 B
$30.48 -2.46%
Close of 13 Nov 2026
As of 13 Nov 2026, Viridian Therapeutics, Inc.DE (VRDN) has a market capitalization of $3.46B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
-$342.6M
Loss-making
Shares outstanding
113,558,449
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 497 →- #68Viking TherapeuticsVKTX$3.52B
- #69Arcutis BiotherapeuticsARQT$3.48B
- #70Viridian Therapeutics, Inc.DEVRDN$3.46B
- #71Parabilis MedicinesPBLS$3.42B
- #72Dyne TherapeuticsDYN$3.19B
What if Viridian Therapeutics, Inc.DE were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Viridian Therapeutics, Inc.DE are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.